Delivery Order SPE2DB22D1106-SPE2DB23FEXU5
Award Date 9/5/23
Potential Completion Date 9/6/23
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,597.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562216928 units of 1 mg vials of remifentanil. The prime contractor will deliver the remifentanil from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency. Remifentanil is an opioid analgesic used for general anesthesia and intensive care unit sedation. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and...
- The Defense Logistics Agency awarded a $353,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 mg vials of the opioid analgesic remifentanil. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by July 31, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The order was placed under an existing DLA pharmaceuticals contract vehicle to...
- The Defense Logistics Agency awarded a $4,596.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561422255 units of 1 mg vials of remifentanil. The one-day contract has a period of performance from July 6 to July 7, 2023, with all work to be conducted by the prime contractor at its facility located in Conshohocken, Pennsylvania. The DLA supports military treatment facilities and healthcare providers through its medical product procurement and distribution activities....
- <p>This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corporation $708 to supply 1 mg vials of remifentanil, an opioid analgesic, by October 19, 2023. The firm fixed price order was awarded on October 18, 2023 to the vendor's Conshohocken, Pennsylvania location under an existing contract vehicle. No set-aside provisions were applied to this order for remifentanil, which will support the Defense Logistics Agency's medical supply chain needs.</p>
- The Defense Logistics Agency awarded a $2,318 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562047331 REMIFENTANIL 1 MG VIALS. As the prime contractor, Amerisourcebergen will supply the opioid anesthetic to the DLA under a contract ending September 5, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania to support the DLA's medical supply logistics programs. No subcontractors or...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $3,612.50 to provide 4561740719 units of the drug remifentanil hydrochloride in 1 mg vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen is well positioned to fulfill this small order for...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.15 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This firm fixed-price contract, issued on December 26, 2025, with completion expected by December 29, 2025, represents a competitively awarded order with no set-aside designation. The pharmaceutical products will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $1,919.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This competitively awarded contract, which has no set-aside designation, was executed on July 9, 2025, with an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.00 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This firm fixed-price contract, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a competitive award with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Remifentanil is a potent synthetic...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials with a ceiling value of $2,130.18. The contract, issued on December 29, 2025, with an ultimate completion date of December 30, 2025, represents a firm fixed price delivery order under a competitive procurement with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEXU5Delivery Order
The Defense Logistics Agency awarded a $2,354 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562048946 units of 1 mg vials of remifentanil. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 6, 2023 in support of DLA programs. Remifentanil is an opioid analgesic for medical use as an anesthetic adjunct. This order was awarded under an existing DLA pharmaceutical supply vehicle and no set aside designation was specified.
Generated 12/20/23, 12:21 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/5/23 |